InNexus Biotechnology, Inc.
IXSBFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$12627
P/E Ratio—
52W High$0.0001
52W Low$0.000001
InNexus Biotechnology, Inc.（IXSBF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IXSBF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2010-06 | 2009-06 | 2008-06 | 2007-06 | 2006-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | -347.90% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.01B | $0.01B | $0.01B | $0.00B |
| Operating Income | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.01B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.07 | $-0.11 | $-0.11 | $-0.13 | $-0.12 |
| Wtd Avg Shares | 0.10B | 0.08B | 0.06B | 0.04B | 0.03B |
| EBITDA | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CAD · B
深入了解InNexus Biotechnology, Inc.
关于InNexus Biotechnology, Inc.（IXSBF）损益表
InNexus Biotechnology, Inc.（IXSBF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2010财年，IXSBF实现营收$0.00B，毛利润$0.00B（毛利率—），净利润($0.01B)（净利率—）。
常见问题
IXSBF · 4 问InNexus Biotechnology, Inc.（IXSBF）2010财年营收为$0.00B，同比down—%。
IXSBF revenueIXSBF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09